Montelukast for Prevention & Treatment of OHSS

NCT03794037 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

20

Enrollment

OTHER

Sponsor class

Stopped no fund

Conditions

Ovarian Hyperstimulation Syndrome

Interventions

DRUG: dydrgesterone 10 mg( tab)/12hs/14 days
COMBINATION_PRODUCT: montelukast 10 mg(tab) oral/24hs/ 7 days dydrgesterone 10 mg( tab) oral/12hs/14 days

Sponsor

Benha University

Collaborators

[object Object]